These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14996599)

  • 1. Relation of fasting insulin plasma levels to restenosis after elective coronary stent implantation in patients without diabetes mellitus.
    Radke PW; Voswinkel M; Reith M; Kaiser A; Haager PK; Hanrath P; Hoffmann R
    Am J Cardiol; 2004 Mar; 93(5):639-41. PubMed ID: 14996599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients.
    Babalik E; Gürmen T; Orhan L; Bulur H; Gülbaran M; Ersanli M; Oztürk S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):306-12. PubMed ID: 12594693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study.
    Natarajan MK; Strauss BH; Rokoss M; Buller CE; Mancini GB; Xie C; Sheth TN; Goodhart D; Cohen EA; Seidelin P; Harper W; Gerstein HC
    Cardiovasc Revasc Med; 2012; 13(2):95-100. PubMed ID: 22296781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of restenosis after excimer laser angioplasty to fasting insulin levels.
    Rabbani LE; Edelman ER; Ganz P; Selwyn AP; Loscalzo J; Bittl JA
    Am J Cardiol; 1994 Feb; 73(5):323-7. PubMed ID: 8109544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of C-reactive protein after coronary stent implantation.
    Gottsauner-Wolf M; Zasmeta G; Hornykewycz S; Nikfardjam M; Stepan E; Wexberg P; Zorn G; Glogar D; Probst P; Maurer G; Huber K
    Eur Heart J; 2000 Jul; 21(14):1152-8. PubMed ID: 10924298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure.
    Antoniucci D; Valenti R; Migliorini A; Moschi G; Trapani M; Bolognese L; Santoro GM; Cerisano G
    Catheter Cardiovasc Interv; 2001 Dec; 54(4):420-6. PubMed ID: 11747173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term angiographic follow-up after successful repeat balloon angioplasty for in-stent restenosis.
    Galassi AR; Foti R; Azzarelli S; Condorelli G; Coco G; Ragusa A; Russo G; Grasso A; Bonaccorso C; Tamburino C; Giuffrida G
    Clin Cardiol; 2001 Apr; 24(4):334-40. PubMed ID: 11303704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome.
    Liistro F; Stankovic G; Di Mario C; Takagi T; Chieffo A; Moshiri S; Montorfano M; Carlino M; Briguori C; Pagnotta P; Albiero R; Corvaja N; Colombo A
    Circulation; 2002 Apr; 105(16):1883-6. PubMed ID: 11997271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
    Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
    J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culprit coronary lesions requiring percutaneous coronary intervention after vascular surgery often arise from in-stent restenosis of bare metal stents.
    Garcia S; Murray ST; Moritz TE; Pierpont G; Goldman S; Larsen GC; Littooy F; Ward HB; McFalls EO
    Ann Vasc Surg; 2010 Jul; 24(5):596-601. PubMed ID: 20579583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation.
    Qin Z; Zheng FW; Zeng C; Zhou K; Geng Y; Wang JL; Li YP; Ji QW; Zhou YJ
    Chin Med J (Engl); 2017 Oct; 130(19):2326-2332. PubMed ID: 28836572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of in-stent restenosis with sirolimus-eluting-stents -- a six month clinical and angiographic follow-up.
    Rau M; Maikowski C; Weber M; Keil E; Elsässer A; Möllmann H; Hamm C
    Z Kardiol; 2005 Nov; 94(11):742-7. PubMed ID: 16258776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting.
    Hong MK; Park SW; Mintz GS; Lee NH; Lee CW; Kim JJ; Park SJ
    Am J Cardiol; 2000 Feb; 85(4):441-5. PubMed ID: 10728947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus: The RESERVOIR Clinical Trial.
    Romaguera R; Gómez-Hospital JA; Gomez-Lara J; Brugaletta S; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Montanya E; Fernandez-Ortiz A; Alfonso F; Valgimigli M; Sabate M; Cequier A
    JACC Cardiovasc Interv; 2016 Jan; 9(1):42-50. PubMed ID: 26762910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy.
    Pohl T; Kupatt C; Steinbeck G; Boekstegers P
    Z Kardiol; 2005 Jun; 94(6):405-10. PubMed ID: 15940441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women.
    Lawlor DA; Fraser A; Ebrahim S; Smith GD
    PLoS Med; 2007 Aug; 4(8):e263. PubMed ID: 17760500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of preprocedural hemoglobin A1c on the efficacy of sirolimus-eluting and paclitaxel-eluting stents.
    Sawai T; Miyahara M; Nakajima H; Nakamori S; Sakai M; Tamada H; Tanigawa T; Yamada N; Nakamura M; Ito M
    Cardiovasc Interv Ther; 2012 May; 27(2):72-83. PubMed ID: 22623000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.